Harvard Business Review December 14, 2017
David Blumenthal, M.D.

The U.S. health care system is begging for disruption. It costs way too much ($3.3 trillion last year) and delivers too little value. Hundreds of millions of Germans, French, English, Scandinavians, Dutch, Danish, Swiss, Canadians, New Zealanders, and Australians get comparable or better health services for half of what we pay. For most Americans, care is not only expensive but is also fragmented, inconvenient, and physically inaccessible, especially to the sickest and frailest among us.

It should come as no surprise, then, that when titans of our private, for-profit health care sector — like Aetna, CVS, UnitedHealth Group (UHG), and DaVita — strike out in new directions, stakeholders react with fascination and excitement. Could this be it? Is free-market magic...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Health System / Hospital, Healthcare System, Mergers & Acquisitions / JV, Payer, Retail care
Retrieve Medical Holdings Inc. Announces Letter of Intent to Acquire Cúratus LLC, Strengthening Al-Powered Healthcare Solutions
Solera Senior Living Adds 5 Communities With Acquisition of SageLife
Labcorp to buy Opko unit’s cancer test assets for up to $225M
Gleamer expands AI imaging portfolio with acquisitions of Pixyl and Caerus Medical
Roche broadens obesity drug plans with $1.65B Zealand deal

Share This Article